General Information of Drug Off-Target (DOT) (ID: OTJLEFX1)

DOT Name BTB/POZ domain-containing protein KCTD20 (KCTD20)
Synonyms Potassium channel tetramerization domain containing 20
Gene Name KCTD20
Related Disease
Cocaine addiction ( )
Non-small-cell lung cancer ( )
UniProt ID
KCD20_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF16017
Sequence
MNVHRGSDSDRLLRQEASCLVDDTLAVAQEKEANSLASSGPHNLTYPLGPRNEDLSLDYA
SQPANLQFPHIMPLAEDIKGSCFQSGNKRNHEPFIAPERFGNSSVGFGSNSHSQAPEKVT
LLVDGTRFVVNPQIFTAHPDTMLGRMFGPGREYNFTRPNEKGEYEIAEGISATVFRTVLD
YYKTGIINCPDGISIPDLRDTCDYLCINFDFNTIRCQDLSALLHELSNDGAHKQFDHYLE
ELILPIMVGCAKKGERECHIVVLTDEDSVDWDEDHPPPMGEEYSQILYSSKLYRFFKYIE
NRDVAKTVLKERGLKNIRIGIEGYPTCKEKIKRRPGGRSEVIYNYVQRPFIQMSWEKEEG
KSRHVDFQCVRSKSLTNLVAAGDDVLEDQEILMHHPPQVDELDRLNAPLSQMASNDFQD
Function Promotes the phosphorylation of AKT family members.

Molecular Interaction Atlas (MIA) of This DOT

2 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Cocaine addiction DISHTRXG Strong Genetic Variation [1]
Non-small-cell lung cancer DIS5Y6R9 Strong Altered Expression [2]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
8 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of BTB/POZ domain-containing protein KCTD20 (KCTD20). [3]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of BTB/POZ domain-containing protein KCTD20 (KCTD20). [4]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate increases the expression of BTB/POZ domain-containing protein KCTD20 (KCTD20). [5]
Resveratrol DM3RWXL Phase 3 Resveratrol increases the expression of BTB/POZ domain-containing protein KCTD20 (KCTD20). [7]
Genistein DM0JETC Phase 2/3 Genistein increases the expression of BTB/POZ domain-containing protein KCTD20 (KCTD20). [7]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of BTB/POZ domain-containing protein KCTD20 (KCTD20). [8]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of BTB/POZ domain-containing protein KCTD20 (KCTD20). [9]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of BTB/POZ domain-containing protein KCTD20 (KCTD20). [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of BTB/POZ domain-containing protein KCTD20 (KCTD20). [6]
------------------------------------------------------------------------------------

References

1 Cocaine'omics: Genome-wide and transcriptome-wide analyses provide biological insight into cocaine use and dependence.Addict Biol. 2020 Mar;25(2):e12719. doi: 10.1111/adb.12719. Epub 2019 Feb 8.
2 Kctd20 promotes the development of non-small cell lung cancer through activating Fak/AKT pathway and predicts poor overall survival of patients.Mol Carcinog. 2017 Sep;56(9):2058-2065. doi: 10.1002/mc.22660. Epub 2017 May 2.
3 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
4 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
5 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
6 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
7 Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds. Toxicol Appl Pharmacol. 2009 Apr 1;236(1):85-96.
8 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
9 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
10 Gene expression changes in primary human nasal epithelial cells exposed to formaldehyde in vitro. Toxicol Lett. 2010 Oct 5;198(2):289-95.